Related Experiment Video

Updated: Jan 29, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

785

Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway

Ma Yanchun1, Wang Yi1, Wang Lu1

  • 1Department of Pathology, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China; Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China; Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, Shanxi 030001, PR China.

European Journal of Pharmacology
|February 20, 2019
PubMed

Insights

Triptolide effectively inhibits Esophageal Squamous Cell Cancer (ESCC) progression by inducing cell cycle arrest and apoptosis. This study suggests triptolide as a potential therapeutic candidate for ESCC treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Triptolide, derived from a traditional Chinese herb, exhibits anti-tumor properties.
  • The anti-cancer effects of triptolide on Esophageal Squamous Cell Cancer (ESCC) remain largely uninvestigated.

Purpose of the Study:

  • To elucidate the anti-cancer effects of triptolide on ESCC cells.
  • To investigate the molecular mechanisms underlying triptolide's action in ESCC.

Main Methods:

  • In vitro assays assessing cell proliferation, invasion, migration, and survivability.
  • Cell cycle analysis and apoptosis assays.
  • Western blotting to analyze key protein expressions and signaling pathways (p53, MAPK/ERK).
  • In vivo validation using a mouse xenograft model.

Main Results:

  • Triptolide significantly inhibited ESCC cell proliferation, invasion, migration, and survival.
  • Triptolide induced G1/S phase cell cycle arrest and apoptosis via cyclin D1-CDK4/6 and caspase activation.
  • Triptolide modulated apoptosis through the p53 pathway and metastasis via the MAPK/ERK pathway.
  • Inhibition of ESCC was confirmed in a mouse xenograft model.

Conclusions:

  • Triptolide demonstrates significant anti-cancer activity against ESCC in vitro and in vivo.
  • Triptolide exerts its effects by regulating cell cycle, apoptosis, and metastasis signaling pathways.
  • Triptolide shows promise as a potential therapeutic agent for Esophageal Squamous Cell Cancer.
Keywords:
ESCCMAPK/ERK pathwayMetastasisProliferationTriptolide

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

4.0K
Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System08:54

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System

Published on: March 20, 2016

10.3K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.3K